Recombinant human C1 esterase inhibitor as short-term
prophylaxis in patients with hereditary angioedema

J 2020

Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema

VALERIEVA, Anna, Maria STAEVSKA, Milos JESENAK, Katarina HRUBISKOVA, Marta SOBOTKOVA et. al.

Basic information

Original name

Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema

Authors

VALERIEVA, Anna (100 Bulgaria, guarantor), Maria STAEVSKA (100 Bulgaria), Milos JESENAK (703 Slovakia), Katarina HRUBISKOVA (703 Slovakia), Marta SOBOTKOVA (203 Czech Republic), Radana ZACHOVA (203 Czech Republic), Roman HAKL (203 Czech Republic, belonging to the institution), Sladjana ANDREJEVIC (688 Serbia), Tobias SUITER (528 Netherlands), Vesna GRIVCHEVA-PANOVSKA (807 North Macedonia), Ljerka KARADZA-LAPIC (191 Croatia), Daniel SOTERES (840 United States of America), Ralph SHAPIRO (840 United States of America), Jeffrey RUMBYRT (840 United States of America), Raffi TACHDJIAN (840 United States of America), Vinay MEHTA (840 United States of America), F. Ida HSU (840 United States of America) and Andrea ZANICHELLI (380 Italy)

Edition

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, AMSTERDAM, ELSEVIER, 2020, 2213-2198

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30102 Immunology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 8.861

RIV identification code

RIV/00216224:14110/20:00115435

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.jaip.2019.08.011

UT WoS

000512964500062

Keywords in English

C1-INHIBITOR; ATTACKS; DEFICIENCY; EFFICACY

Abstract

V originále

Hereditary angioedema (HAE), an inherited deficiency offunctional C1 esterase inhibitor (C1-INH), is characterized byrecurrent episodes of disabling and often painful swelling insubcutaneous and/or submucosal tissues.1HAE attacks aregenerally unpredictable, but triggers for an attack can includehaving a dental or medical procedure (eg, surgery), other trauma,or stress. A preemptive management plan for patients under-going these types of situations may reduce the risk of HAE at-tacks. Recommendations include administration of short-termprophylaxis in patients with HAE before invasive medical pro-cedures, especially those involving the upper airways or digestivetract, with C1-INH concentrate typically the medication ofchoice.

Citovat

VALERIEVA, Anna, Maria STAEVSKA, Milos JESENAK, Katarina HRUBISKOVA, Marta SOBOTKOVA, Radana ZACHOVA, Roman HAKL, Sladjana ANDREJEVIC, Tobias SUITER, Vesna GRIVCHEVA-PANOVSKA, Ljerka KARADZA-LAPIC, Daniel SOTERES, Ralph SHAPIRO, Jeffrey RUMBYRT, Raffi TACHDJIAN, Vinay MEHTA, F. Ida HSU and Andrea ZANICHELLI. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. AMSTERDAM: ELSEVIER, 2020, vol. 8, No 2, p. 799-802. ISSN 2213-2198. Available from: https://dx.doi.org/10.1016/j.jaip.2019.08.011.

@article{1637706,
   author = {Valerieva, Anna and Staevska, Maria and Jesenak, Milos and Hrubiskova, Katarina and Sobotkova, Marta and Zachova, Radana and Hakl, Roman and Andrejevic, Sladjana and Suiter, Tobias and GrivchevaandPanovska, Vesna and KaradzaandLapic, Ljerka and Soteres, Daniel and Shapiro, Ralph and Rumbyrt, Jeffrey and Tachdjian, Raffi and Mehta, Vinay and Hsu, F. Ida and Zanichelli, Andrea},
   article_location = {AMSTERDAM},
   article_number = {2},
   doi = {http://dx.doi.org/10.1016/j.jaip.2019.08.011},
   keywords = {C1-INHIBITOR; ATTACKS; DEFICIENCY; EFFICACY},
   language = {eng},
   issn = {2213-2198},
   journal = {JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE},
   title = {Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema},
   url = {http://dx.doi.org/10.1016/j.jaip.2019.08.011},
   volume = {8},
   year = {2020}
}

TY  - JOUR
ID  - 1637706
AU  - Valerieva, Anna - Staevska, Maria - Jesenak, Milos - Hrubiskova, Katarina - Sobotkova, Marta - Zachova, Radana - Hakl, Roman - Andrejevic, Sladjana - Suiter, Tobias - Grivcheva-Panovska, Vesna - Karadza-Lapic, Ljerka - Soteres, Daniel - Shapiro, Ralph - Rumbyrt, Jeffrey - Tachdjian, Raffi - Mehta, Vinay - Hsu, F. Ida - Zanichelli, Andrea
PY  - 2020
TI  - Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema
JF  - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
VL  - 8
IS  - 2
SP  - 799-802
EP  - 799-802
PB  - ELSEVIER
SN  - 22132198
KW  - C1-INHIBITOR
KW  - ATTACKS
KW  - DEFICIENCY
KW  - EFFICACY
UR  - http://dx.doi.org/10.1016/j.jaip.2019.08.011
L2  - http://dx.doi.org/10.1016/j.jaip.2019.08.011
N2  - Hereditary angioedema (HAE), an inherited deficiency offunctional C1 esterase inhibitor (C1-INH), is characterized byrecurrent episodes of disabling and often painful swelling insubcutaneous and/or submucosal tissues.1HAE attacks aregenerally unpredictable, but triggers for an attack can includehaving a dental or medical procedure (eg, surgery), other trauma,or stress. A preemptive management plan for patients under-going these types of situations may reduce the risk of HAE at-tacks. Recommendations include administration of short-termprophylaxis in patients with HAE before invasive medical pro-cedures, especially those involving the upper airways or digestivetract, with C1-INH concentrate typically the medication ofchoice.
ER  -

VALERIEVA, Anna, Maria STAEVSKA, Milos JESENAK, Katarina HRUBISKOVA, Marta SOBOTKOVA, Radana ZACHOVA, Roman HAKL, Sladjana ANDREJEVIC, Tobias SUITER, Vesna GRIVCHEVA-PANOVSKA, Ljerka KARADZA-LAPIC, Daniel SOTERES, Ralph SHAPIRO, Jeffrey RUMBYRT, Raffi TACHDJIAN, Vinay MEHTA, F. Ida HSU and Andrea ZANICHELLI. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. \textit{JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE}. AMSTERDAM: ELSEVIER, 2020, vol.~8, No~2, p.~799-802. ISSN~2213-2198. Available from: https://dx.doi.org/10.1016/j.jaip.2019.08.011.

Detailed Information on Publication Record